Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome

Tumor lysis syndrome (TLS) is a life-threatening oncological emergency, in which control of serum uric acid (S-UA) levels is important. S-UA-lowering efficacy of a new xanthine oxidase inhibitor, febuxostat, was retrospectively evaluated in seven patients with hematological malignancies who were at...

Descripción completa

Detalles Bibliográficos
Autores principales: TAKAI, MIHOKO, YAMAUCHI, TAKAHIRO, FUJITA, KEI, LEE, SHIN, OOKURA, MIYUKI, KISHI, SHINJI, URASAKI, YOSHIMASA, YOSHIDA, AKIRA, IWASAKI, HIROMICHI, UEDA, TAKANORI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156226/
https://www.ncbi.nlm.nih.gov/pubmed/25202361
http://dx.doi.org/10.3892/ol.2014.2394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156226/
https://www.ncbi.nlm.nih.gov/pubmed/25202361
http://dx.doi.org/10.3892/ol.2014.2394

Ejemplares similares